Management of uninvestigated dyspepsia: A randomized, double-blind, placebo-controlled trial of proton pump inhibitor therapy

Gastroenterology ◽

10.1016/s0016-5085(01)80434-0 ◽

2001 ◽

Vol 120 (5) ◽

pp. A88-A88

Author(s):

L RABENECK ◽

J SOUCHEK ◽

K WRISTERS ◽

T MENKE ◽

N WRAY ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Management of uninvestigated dyspepsia: A randomized, double-blind, placebo-controlled trial of proton pump inhibitor therapy

Gastroenterology ◽

10.1016/s0016-5085(08)80434-9 ◽

2001 ◽

Vol 120 (5) ◽

pp. A88

Author(s):

Linda Rabeneck ◽

Julianne Souchek ◽

Kimberly Wristers ◽

Terri Menke ◽

Nelda Wray ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2002.07123.x ◽

2002 ◽

Vol 97 (12) ◽

pp. 3045-3051 ◽

Author(s):

Linda Rabeneck ◽

Julianne Souchek ◽

Kimberly Wristers ◽

Terri Menke ◽

Eunice Ambriz ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Download Full-text

A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial

Gut ◽

10.1136/gut.2010.235630 ◽

2011 ◽

Vol 60 (9) ◽

pp. 1182-1188 ◽

Author(s):

G. E. Boeckxstaens ◽

H. Beaumont ◽

J. G. Hatlebakk ◽

D. G. Silberg ◽

K. Bjorck ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Reflux Symptoms

Download Full-text

Effect on Bleeding Prevention of an Intravenous Proton Pump Inhibitor During the Fasting Period After Endoscopic Submucosal Dissection: a Prospective, Randomized, Double-Blind, Placebo-Controlled Trial

Journal of Gastrointestinal Surgery ◽

10.1007/s11605-019-04466-9 ◽

2019 ◽

Vol 24 (11) ◽

pp. 2596-2601

Author(s):

Jai Hoon Yoon ◽

Youn Jeong Kim ◽

Kang Nyeong Lee ◽

Dae Won Jun ◽

Dong Hee Koh ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Endoscopic Submucosal Dissection ◽

Proton Pump ◽

Controlled Trial ◽

Double Blind ◽

Fasting Period ◽

Double Blind Placebo ◽

Submucosal Dissection

Download Full-text

Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial

Alimentary Pharmacology & Therapeutics ◽

10.1046/j.1365-2036.2003.01656.x ◽

2003 ◽

Vol 18 (1) ◽

pp. 109-115 ◽

Author(s):

R. J. F. Laheij ◽

L. G. M . Van Rossum ◽

J. B. M. J. Jansen ◽

F. W. A. Verheugt

Keyword(s):

Proton Pump Inhibitor ◽

Acetylsalicylic Acid ◽

Proton Pump ◽

Controlled Trial ◽

Gastrointestinal Symptoms ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Upper Gastrointestinal Symptoms ◽

Upper Gastrointestinal

Download Full-text

Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse

European Journal of Gastroenterology & Hepatology ◽

10.1097/meg.0b013e32833d56d1 ◽

2010 ◽

Vol 22 (10) ◽

pp. 1182-1188 ◽

Author(s):

Christina Reimer ◽

Peter Bytzer

Keyword(s):

Primary Care ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Primary Care Patients ◽

Symptom Relapse

Download Full-text

Dyspeptic Symptom Development After Discontinuation of a Proton Pump Inhibitor: A Double-Blind Placebo-Controlled Trial

The American Journal of Gastroenterology ◽

10.1038/ajg.2010.81 ◽

2010 ◽

Vol 105 (7) ◽

pp. 1531-1537 ◽

Author(s):

Anna Niklasson ◽

Lina Lindström ◽

Magnus Simrén ◽

Greger Lindberg ◽

Einar Björnsson

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Dyspeptic Symptom ◽

Symptom Development ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

T1079 Discontinuation of Long-Term Proton Pump Inhibitor Therapy in Primary Care Patients a Randomized, Placebo-Controlled Trial in Patients With Symptom Relapse

Gastroenterology ◽

10.1016/s0016-5085(10)62234-2 ◽

2010 ◽

Vol 138 (5) ◽

pp. S-483

Author(s):

Christina Reimer ◽

Peter Bytzer

Keyword(s):

Primary Care ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Primary Care Patients ◽

Symptom Relapse

Download Full-text

Sa1205 LONG-TERM EFFICACY AND SAFETY OF CONTINUOUS VS ON-DEMAND PROTON PUMP INHIBITOR THERAPY IN THE TREATMENT OF BARRETT'S ESOPHAGUS — A MULTICENTRE, RANDOMIZED CONTROLLED TRIAL

Gastroenterology ◽

10.1016/s0016-5085(20)31477-3 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-311

Author(s):

Ping-I Hsu ◽

Sungshuo Kao ◽

Seng-Kee Chuah ◽

Deng-Chyang Wu

Keyword(s):

Randomized Controlled Trial ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Controlled Trial ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Efficacy And Safety ◽

On Demand ◽

Randomized Controlled

Download Full-text

The GABA, agonist baclofen reduces duodeno-gastro-esophageal reflux (DGER) and symptoms in patients with reflux disease refractory to proton pump inhibitor therapy

Gastroenterology ◽

10.1016/s0016-5085(01)80167-0 ◽

2001 ◽

Vol 120 (5) ◽

pp. A34-A34 ◽

Author(s):

G KOEK ◽

D SIFRIM ◽

T DEGREEF ◽

J JANSSENS ◽

J TACK

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Reflux Disease ◽

Proton Pump Inhibitor Therapy ◽

Inhibitor Therapy ◽

Esophageal Reflux ◽

Download Full-text